Amundi
CLB icon

Amundi’s Core Laboratories CLB Stock Holding History

Amundi’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$607K Buy
52,065
+20,208
+63% +$288K ﹤0.01% 1575
2026
Q1 		$535K Buy
31,857
+12,312
+63% +$220K ﹤0.01% 1524
2025
Q4 		$313K Buy
19,545
+5,571
+40% +$82.9K ﹤0.01% 1633
2025
Q3 		$173K Buy
13,974
+3,555
+34% +$41.7K ﹤0.01% 1553
2025
Q2 		$134K Sell
10,419
-15,860
-60% -$188K ﹤0.01% 1639
2025
Q1 		$353K Sell
26,279
-6,689
-20% -$112K ﹤0.01% 1569
2024
Q4 		$600K Buy
32,968
+21,783
+195% +$420K ﹤0.01% 1525
2024
Q3 		$215K Buy
11,185
+2,133
+24% +$42.8K ﹤0.01% 1638
2024
Q2 		$185K Buy
9,052
+759
+9% +$13.4K ﹤0.01% 1588
2024
Q1 		$141K Buy
8,293
+2,390
+40% +$37.6K ﹤0.01% 1703
2023
Q4 		$96.9K Hold
5,903
– – ﹤0.01% 1782
2023
Q3 		$141K Hold
5,903
– – ﹤0.01% 1679
2023
Q2 		$132K Sell
5,903
-408
-6% -$9.23K ﹤0.01% 1709
2023
Q1 		$144K Buy
+6,311
New +$148K ﹤0.01% 1657
2021
Q3 		– Sell
-133,444
Closed -$5.2M – 1576
2021
Q2 		$5.2M Buy
+133,444
New +$4.78M ﹤0.01% 997

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Amundi's CLB Position: Q2 2026 in Review

Amundi increased its Core Laboratories (CLB) stake by 63% in Q2 2026, buying an estimated $288K and bringing the position to 52,065 shares worth $607K. The position accounts for ﹤0.01% of the portfolio, ranked #1575.

Amundi first reported a position in CLB in Q2 2021 and has held it in 15 quarters since. The position peaked at $5.2M in Q2 2021. 187 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Amundi held 52,065 shares of Core Laboratories worth $607K as of Q2 2026.
  • Amundi bought 20,208 Core Laboratories shares in Q2 2026, an estimated $288K.
  • Core Laboratories made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1575 holding.
  • Amundi first reported a position in Core Laboratories in Q2 2021 and has held it in 15 quarters since.
  • Amundi's Core Laboratories position peaked at $5.2M in Q2 2021.
  • 187 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.